Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION USP

Last updated on 2021-02-24 History
Report ID 86522
Drug Identification Number 00436208
Brand name LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name Lidocaine Hydrochloride Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 5mL ANSYR
ATC code C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-11
Estimated end date
Actual end date 2021-02-23
Shortage status Resolved
Updated date 2021-02-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-02-24 English Compare
v8 2021-02-23 French Compare
v7 2021-02-23 English Compare
v6 2021-02-10 French Compare
v5 2021-02-10 English Compare
v4 2019-08-13 French Compare
v3 2019-08-13 English Compare
v2 2019-06-12 French Compare
v1 2019-06-12 English Compare

Showing 1 to 9 of 9